US2011143400A1PendingUtilityA1

Sirna and methods of manufacture

Assignee: OPKO OPHTHALMICS LLCPriority: Sep 8, 2006Filed: Dec 15, 2010Published: Jun 16, 2011
Est. expirySep 8, 2026(~0.1 yrs left)· nominal 20-yr term from priority
C12N 15/1136C12N 15/111C12N 2310/14C12N 2330/30
36
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Double-stranded RNA of about 19 to about 25 nucleotides in length capable of regulating gene expression by RNA interference is provided. Such double-stranded RNA are particularly useful for treating disease or conditions associated with a target mRNA or gene. Methods of manufacture and methods of use of the double-stranded RNA are also provided.

Claims

exact text as granted — not AI-modified
1 . A method of preparing a double-stranded RNA molecule comprising
 (a) synthesizing a first set of two or more RNA sub-strands, wherein the combined length of the first set of sub-strands is from about 19 to about 25 nucleotides,   (b) synthesizing a second set of two or more RNA sub-strands, wherein the combined length of the second set of sub-strands is from about 19 to about 25 nucleotides;   (c) combining the synthesized first and second set of RNA sub-strands under conditions, wherein a double-stranded RNA molecule is formed   
     
     
         2 . The method according to  claim 1 , wherein the RNA strands are chemically synthesized. 
     
     
         3 . The method according to  claim 1 , wherein the RNA strands are enzymatically synthesized. 
     
     
         4 . The method of  claim 1 , wherein the double-stranded RNA molecule comprises a single double stranded region and single stranded regions of about 1 to about 5 nucleotides at the 3′ ends of at least one of the strands of the double-stranded RNA molecule. 
     
     
         5 . The method of  claim 1 , wherein both strands of the double-stranded RNA molecule each have a 3′-overhang from about 1 to about 5 nucleotides. 
     
     
         6 . The method of  claim 1 , wherein both strands of the double-stranded RNA molecule each have a 3′-overhang of about 2 nucleotides. 
     
     
         7 . The method of  claim 1 , wherein each strand has a length from 20-22 nucleotides. 
     
     
         8 . The method of  claim 1 , wherein the double-stranded RNA molecule comprises at least one sugar-modified nucleotide, wherein the 2′-OH group of said sugar-modified nucleotide is replaced by a group selected from H, OR, R, halo, SH, SR, NH 2 , NHR, N(R) 2  or CN, wherein R is C 1 -C 6  alkyl, alkenyl or alkynyl and halo is F, C, Br or I. 
     
     
         9 . The method of  claim 1 , wherein the double stranded RNA molecule comprises at least one backbone-modified nucleotide containing a phosphorothioate group. 
     
     
         10 .- 18 . (canceled) 
     
     
         19 . A method of preparing a double-stranded RNA molecule comprising
 (a) synthesizing a first set of two or more RNA sub-strands, wherein the combined length of the first set of sub-strands is 25 or fewer nucleotides,   (b) synthesizing a second set of two or more RNA sub-strands, wherein the combined length of the second set of sub-strands is 25 or fewer nucleotides;   (c) combining the synthesized first and second set of RNA sub-strands under conditions, wherein a double-stranded RNA molecule is formed.   
     
     
         20 . The method of  claim 19 , wherein the double-stranded RNA molecule comprises a single double stranded region and single stranded regions of about 1 to about 5 nucleotides at the 3′ ends of at least one of the strands of the double-stranded RNA molecule. 
     
     
         21 . The method of  claim 20 , wherein each strand has a length from 20-22 nucleotides. 
     
     
         22 .- 24 . (canceled)

Join the waitlist — get patent alerts

Track US2011143400A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.